Lessons Learnt and the Way Forward for Drug Development Against Isocitrate Lyase from <i>Mycobacterium tuberculosis</i>.

Antil, Monika; Gupta, Vibha

Lessons Learnt and the Way Forward for Drug Development Against Isocitrate Lyase from Mycobacterium tuberculosis.

Antil, Monika; Gupta, Vibha.

Afiliação

Antil M; Department of Biotechnology, Jaypee Institute of Information Technology, Noida - 201309, India.
Gupta V; Department of Biotechnology, Jaypee Institute of Information Technology, Noida - 201309, India.

Protein Pept Lett ; 29(12): 1031-1041, 2022.

Article em En | MEDLINE | ID: mdl-36201276

Assuntos

Isocitrato Liase; Mycobacterium tuberculosis; Isocitrato Liase/genética; Isocitrato Liase/metabolismo; Antituberculosos/farmacologia; Ácidos Graxos/metabolismo; Desenvolvimento de Medicamentos

Palavras-chave

Glyoxylate shunt pathway; Mycobacterium tuberculosis; drug development; isocitrate lyase; phylogenetic analysis; proteogenomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Isocitrato Liase / Mycobacterium tuberculosis Idioma: En Revista: Protein Pept Lett Assunto da revista: BIOQUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google